These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11790911)

  • 21. Performance profiles and cut-off scores on the Memory Assessment Scales.
    O'Bryant SE; Duff K; Fisher J; McCaffrey RJ
    Arch Clin Neuropsychol; 2004 Jun; 19(4):489-96. PubMed ID: 15163450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coverage of the Test of Memory Malingering, Victoria Symptom Validity Test, and Word Memory Test on the Internet: is test security threatened?
    Bauer L; McCaffrey RJ
    Arch Clin Neuropsychol; 2006 Jan; 21(1):121-6. PubMed ID: 16122901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Test of Memory Malingering Performance is unaffected by laboratory-induced pain: implications for clinical use.
    Etherton JL; Bianchini KJ; Greve KW; Ciota MA
    Arch Clin Neuropsychol; 2005 May; 20(3):375-84. PubMed ID: 15797173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A model to approaching and providing feedback to patients regarding invalid test performance in clinical neuropsychological evaluations.
    Carone DA; Iverson GL; Bush SS
    Clin Neuropsychol; 2010; 24(5):759-78. PubMed ID: 20486015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Red flags in the clinical interview may forecast invalid neuropsychological testing.
    Keesler ME; McClung K; Meredith-Duliba T; Williams K; Swirsky-Sacchetti T
    Clin Neuropsychol; 2017 Apr; 31(3):619-631. PubMed ID: 27846775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship between performances on neuropsychological symptom validity testing and the MCMI-III in patients with fibromyalgia.
    Brooks L; Johnson-Greene D; Lattie E; Ference T
    Clin Neuropsychol; 2012; 26(5):816-31. PubMed ID: 22420469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The relation between symptom validity testing and MMPI-2 scores as a function of forensic evaluation context.
    Wygant DB; Sellbom M; Ben-Porath YS; Stafford KP; Freeman DB; Heilbronner RL
    Arch Clin Neuropsychol; 2007 May; 22(4):489-99. PubMed ID: 17350796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probable malingering and performance on the test of variables of attention.
    Henry GK
    Clin Neuropsychol; 2005 Feb; 19(1):121-9. PubMed ID: 15814483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head injury and the ability to feign neuropsychological deficits.
    Vickery CD; Berry DT; Dearth CS; Vagnini VL; Baser RE; Cragar DE; Orey SA
    Arch Clin Neuropsychol; 2004 Jan; 19(1):37-48. PubMed ID: 14670378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A survey of neuropsychologists' beliefs and practices with respect to the assessment of effort.
    Sharland MJ; Gfeller JD
    Arch Clin Neuropsychol; 2007 Feb; 22(2):213-23. PubMed ID: 17284353
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The base rate of suboptimal effort in a pediatric mild TBI sample: performance on the Medical Symptom Validity Test.
    Kirkwood MW; Kirk JW
    Clin Neuropsychol; 2010; 24(5):860-72. PubMed ID: 20182954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analog validation of German-language symptom validity tests and the influence of coaching.
    Merten T; Green P; Henry M; Blaskewitz N; Brockhaus R
    Arch Clin Neuropsychol; 2005 Aug; 20(6):719-26. PubMed ID: 16005815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment instruments measuring malingering used with individuals who have mental retardation: potential problems and issues.
    Hurley KE; Deal WP
    Ment Retard; 2006 Apr; 44(2):112-9. PubMed ID: 16689611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detecting neuropsychological malingering: effects of coaching and information.
    Dunn TM; Shear PK; Howe S; Ris MD
    Arch Clin Neuropsychol; 2003 Mar; 18(2):121-34. PubMed ID: 14591464
    [TBL] [Abstract][Full Text] [Related]  

  • 35. American Academy of Clinical Neuropsychology Consensus Conference Statement on the neuropsychological assessment of effort, response bias, and malingering.
    Heilbronner RL; Sweet JJ; Morgan JE; Larrabee GJ; Millis SR;
    Clin Neuropsychol; 2009 Sep; 23(7):1093-129. PubMed ID: 19735055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison of WMT, CARB, and TOMM failure rates in non-head injury disability claimants.
    Gervais RO; Rohling ML; Green P; Ford W
    Arch Clin Neuropsychol; 2004 Jun; 19(4):475-87. PubMed ID: 15163449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using likelihood ratios to detect invalid performance with performance validity measures.
    Meyers JE; Miller RM; Thompson LM; Scalese AM; Allred BC; Rupp ZW; Dupaix ZP; Junghyun Lee A
    Arch Clin Neuropsychol; 2014 May; 29(3):224-35. PubMed ID: 24499725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuropsychological assessment of malingering].
    Merten T
    Fortschr Neurol Psychiatr; 2002 Mar; 70(3):126-38. PubMed ID: 11880945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Estimating the predictive value of the Test of Memory Malingering: an illustrative example for clinicians.
    O'Bryant SE; Lucas JA
    Clin Neuropsychol; 2006 Sep; 20(3):533-40. PubMed ID: 16895864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the appropriateness of multiple symptom validity indices in psychotic and non-psychotic psychiatric populations.
    Schroeder RW; Marshall PS
    Clin Neuropsychol; 2011 Apr; 25(3):437-53. PubMed ID: 21391153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.